Page 23

Dor (2014) 22
melhoria da qualidade de vida num doente on- 3. Smith TJ, Coyne PJ. How to use implantable intrathecal drug deliv-
cológico em fase terminal. ery systems for refractory cancer pain, Supportive Oncology. 2003;
1:73-6.
4. Deer TR, Smith HS, Burton AW, et al. Comprehensive consensus
Conclusão based guidelines on intrathecal drug delivery systems in the treatment
of pain caused by cancer pain. Pain Physician. 2011;14:E283-E312.
Em doentes selecionados, o tratamento da 5. Lamer T. Treatment of cancer-related pain: When orally administered
dor através de SIII em conjunto com o trata- medications fail. Mayo Clin Proc. 1994;69:473-80.
mento médico integrado tem mais sucesso do 6. Staats P. Neuraxial infusion for pain control: When, why, and what to
do after the implant. Oncology. 1999;13:58-62.
que o tratamento médico por si só, com me- 7. Burton A, Rajagopal A, Shah H, et al. Epidural and intrathecal anal-
lhor alívio da dor, menor toxicidade e maior gesia is effective in treating refractory cancer pain. Pain Med.
sobrevida 3,14 . O objetivo da terapêutica intrate- 2004;5:239-47.
cal é o de preservar a qualidade de vida e 8. DeVulder J, Ghys L, Dhondt W, Rolly G. Spinal analgesia in terminal
care: Risk versus benefit. J Pain Symptom Manage. 1994;9:75-81.
autonomia do doente, independentemente do 9. Hassenbusch S, Pillay P, Magdinec M, et al. Constant infusion of
prognóstico. morphine for intractable cancer pain using an implanted pump. J
Neurosurg. 1990;73:405-9.
Este caso clínico evidencia ainda que a dose 10. Onofrio B, Yaksh T. Long-term pain relief produced by intrathecal
de morfina intratecal pode ser aumentada pro- morphine infusion in 53 patients. J Neurosurg. 1990;72:200-9.
gressivamente até ao controlo álgico satisfatório, 11. Penn R, Paice J. Chronic intrathecal morphine for intractable pain.
J Neurosurg. 1987;67:182-6.
desde que sejam cuidadosamente monitoriza- 12. Stearns L, Boortz-Marx R, Pen S, Friehs G. Intrathecal drug delivery
dos os efeitos laterais. for the management of cancer Pain, a multidisciplinary consensus
of best clinical Practices. J Support Oncol. 2005;3:399-408.
Bibliografia 13. Mercadante S, Porzio G, Gebbia V. Spinal analgesia for advanced
cancer patients: update. CritVer Oncol/Hematol. 2011;doi:10.1016/
1. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KL, Grond S. critrevonc. 2011;05:007.
Symptoms during cancer pain treatment following WHO-guidelines: 14. Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an
A longitudinal follow-up study of symptom prevalence, severity and implantable drug delivery system compared with comprehensive
etiology. Pain. 2001;93:247-57. medical management for refractory cancer pain: impact on pain,
2. Vissers KC, Besse K, Wagemans M, et al. Pain in patients with drug-related toxicity, and survival. Journal of Clinical Oncology.
cancer. Pain Practice. 2011;11(5):453-75. 2002;20:4040-9.

DOR

22